Article

Advancing Chemogenomic Strategies for Functional Precision Medicine in Relapsed/Refractory T-ALL and ETP-ALL: TheGimema ALL2720 Trial

2026-03-08

Abstract excerpt

<title>Abstract</title> <p> Despite the vast amount of cancer genomic data, linking mutations to drug efficacy remains challenging. National efforts integrating <italic>ex vivo</italic> drug response profiling (DRP) with clinical genomics are rare. To address this gap, we designed the GIMEMA ALL2720 trial (NCT04582487), a multicenter study evaluating a chemogenomic-driven approach in T-cell acute lymphoblastic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 350d1b3c-1e88-5681-bdeb-5ad2d5a60d61
DOI: 10.21203/rs.3.rs-8620646/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Advancing Chemogenomic Strategies for Functional Precision Medicine in Relapsed/Refractory T-ALL and ETP-ALL: TheGimema ALL2720 TrialDOI 10.21203/rs.3.rs-8620646/v1Read

Drug response profiling guides precision therapy in relapsed and refractory childhood acute lymphoblastic leukemiaSemantic proximity Read

Functional Precision Medicine Enhances Clinical Outcomes of Relapsed/Refractory Pediatric and Adolescent Cancer PatientsSemantic proximity Read

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study.Semantic proximity Read

Multi-omics molecular phenotyping of childhood acute lymphoblastic leukemia cell lines reveals novel drug vulnerabilitiesSemantic proximity Read

Incorporating tumor genomic profiling and drug screening through circulating tumor cell- derived organoids into clinical practice for the management of Gastrointestinal CancersSemantic proximity Read

Novel clinical trial designs emerging from the molecular reclassification of cancerSemantic proximity Read

Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell linesSemantic proximity Read

Precision Oncology: Targeting Genomic Alterations and Cancer Signaling with Integrative Multi-Omics, Deep Learning and Network Biology in Medical Oncology (Preprint)Semantic proximity Read

Mutational and functional genetics mapping of chemotherapy resistance mechanisms in relapsed acute lymphoblastic leukemia.Semantic proximity Read

Ex Vivo Drug Responses and Molecular Profiles of 597 Pediatric Acute Lymphoblastic Leukemia PatientsSemantic proximity Read

Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptomeSemantic proximity Read

Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemiaSemantic proximity Read